Dako A/S (Acquired by Agilent Technologies, Inc.) To Collaborate With Merck & Co., Inc. On Development Of Companion Diagnostics For Cancer Treatment

GLOSTRUP, Denmark, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck’s development pipeline.

Help employers find you! Check out all the jobs and post your resume.